Entering text into the input field will update the search result below

Theravance Biopharma GAAP EPS of -$0.34 misses by $0.23, revenue of $13.2M misses by $1.28M

  • Theravance Biopharma press release (NASDAQ:TBPH): Q1 GAAP EPS of -$0.34 misses by $0.23.
  • Revenue of $13.2M (-7.4% Y/Y) misses by $1.28M.

Recommended For You

More Trending News

About TBPH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TBPH--
Theravance Biopharma, Inc.